Over the past decade, NGS technologies have moved at a rapid pace, dramatically reducing costs and making genome sequencing more routine. What was once unthinkable is now possible. However, most genomes are still sequenced from DNA extracted from multiple cells, which misses differences between cells that could be crucial in controlling gene expression, cell behavior, and drug response. Still, challenges for single-cell sequencing remain, including cell isolation, DNA amplification and bioinformatics. As the techniques are being refined, subtle differences between cells, such as the tiny genomic rearrangements, will emerge.
CHI's Single-Cell Sequencing conference focuses on the links between cell variation in tissues and organ function and furtherelucidates the origins of diseases. To view the agenda, visit http://www.healthtech.com/single-cell-sequencing.
CHI's Single-Cell Sequencing conference focuses on the links between cell variation in tissues and organ function and furtherelucidates the origins of diseases. To view the agenda, visit http://www.healthtech.com/single-cell-sequencing.